Public Profile

DIEVINI HOPP BIOTECH HOLDING

DIEVINI HOPP BIOTECH HOLDING, headquartered in Germany, is a prominent player in the biotechnology sector, focusing on innovative solutions for healthcare and life sciences. Founded in 2015, the company has rapidly established itself as a leader in developing cutting-edge biopharmaceuticals and advanced therapies, particularly in the fields of oncology and rare diseases. With a commitment to research and development, DIEVINI HOPP BIOTECH HOLDING offers a unique portfolio of products that leverage state-of-the-art technology and scientific expertise. The company’s strategic partnerships and collaborations have further enhanced its market position, enabling it to deliver transformative therapies that address unmet medical needs. Recognised for its contributions to the biotech industry, DIEVINI HOPP BIOTECH HOLDING continues to drive innovation and improve patient outcomes on a global scale.

DitchCarbon Score

How does DIEVINI HOPP BIOTECH HOLDING's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

DIEVINI HOPP BIOTECH HOLDING's score of 20 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.

18%

Let us know if this data was useful to you

DIEVINI HOPP BIOTECH HOLDING's reported carbon emissions

DIEVINI HOPP BIOTECH HOLDING, headquartered in Germany, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of specific emissions data, it is essential to note that many companies in the biotech sector are increasingly focusing on sustainability and reducing their carbon footprints. This often includes setting science-based targets and committing to various climate initiatives. However, without concrete information from DIEVINI HOPP BIOTECH HOLDING, it is unclear what specific actions or commitments they may have in place regarding carbon emissions and climate change mitigation.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DIEVINI HOPP BIOTECH HOLDING's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DIEVINI HOPP BIOTECH HOLDING is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DIEVINI HOPP BIOTECH HOLDING is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers